Phillip Minar

829 total citations
40 papers, 434 citations indexed

About

Phillip Minar is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Phillip Minar has authored 40 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 18 papers in Immunology and 14 papers in Epidemiology. Recurrent topics in Phillip Minar's work include Inflammatory Bowel Disease (31 papers), Microscopic Colitis (14 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). Phillip Minar is often cited by papers focused on Inflammatory Bowel Disease (31 papers), Microscopic Colitis (14 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). Phillip Minar collaborates with scholars based in United States, Netherlands and Israel. Phillip Minar's co-authors include Lee A. Denson, Michael J. Rosen, Kimberly Jackson, Yi‐Ting Tsai, Ruben J. Colman, Tomoyuki Mizuno, Jeffrey S. Hyams, Shehzad A. Saeed, Alexander A. Vinks and Joshua D. Noe and has published in prestigious journals such as Gastroenterology, The Journal of Pediatrics and Clinical Pharmacology & Therapeutics.

In The Last Decade

Phillip Minar

39 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phillip Minar United States	12	317	215	207	84	70	40	434
B G Feagan Canada	7	369 1.2×	200 0.9×	262 1.3×	90 1.1×	21 0.3×	28	512
Francisco Fidencio Cons Molina Colombia	5	283 0.9×	120 0.6×	235 1.1×	95 1.1×	23 0.3×	8	414
Ivan Ferkolj Slovenia	11	276 0.9×	111 0.5×	193 0.9×	120 1.4×	25 0.4×	23	416
Timothy E. Ritter United States	11	279 0.9×	89 0.4×	215 1.0×	110 1.3×	13 0.2×	38	442
Jacqueline Jossen United States	10	263 0.8×	115 0.5×	204 1.0×	86 1.0×	46 0.7×	13	358
Ilia Tikhonov United States	8	172 0.5×	90 0.4×	136 0.7×	91 1.1×	25 0.4×	14	282
Ana Vieira Portugal	9	222 0.7×	91 0.4×	154 0.7×	81 1.0×	16 0.2×	12	301
Alexandre Aubourg France	7	166 0.5×	119 0.6×	125 0.6×	57 0.7×	13 0.2×	13	299
Ana Rita Gonçalves Portugal	9	283 0.9×	78 0.4×	227 1.1×	124 1.5×	18 0.3×	28	374
Pauline Wils France	14	353 1.1×	111 0.5×	276 1.3×	123 1.5×	11 0.2×	43	417

Countries citing papers authored by Phillip Minar

Since Specialization

Citations

This map shows the geographic impact of Phillip Minar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Minar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Minar more than expected).

Fields of papers citing papers by Phillip Minar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Minar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Minar. The network helps show where Phillip Minar may publish in the future.

Co-authorship network of co-authors of Phillip Minar

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Minar. A scholar is included among the top collaborators of Phillip Minar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Minar. Phillip Minar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Irie, Kei, Phillip Minar, Brendan M. Boyle, et al.. (2025). Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World Data. Therapeutic Drug Monitoring. 48(1). 98–104. 1 indexed citations

Samuels, Abigail, Kei Irie, Tomoyuki Mizuno, et al.. (2025). Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease. Clinical and Translational Science. 18(2). e70086–e70086. 1 indexed citations

Irie, Kei, Phillip Minar, Brendan M. Boyle, et al.. (2025). Hybrid Population Pharmacokinetic–Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn’s Disease. Clinical Pharmacokinetics. 64(11). 1669–1679. 2 indexed citations

Acord, Michael R., Christopher G. Anton, Jesse Courtier, et al.. (2025). Magnetic resonance imaging for suspected perianal Crohn's disease in children: a multi-reader agreement study. European Radiology. 35(9). 5856–5863.

Minar, Phillip, Ruben J. Colman, Nanhua Zhang, Tomoyuki Mizuno, & Alexander A. Vinks. (2024). Precise infliximab exposure and pharmacodynamic control to achieve deep remission in paediatric Crohn’s disease (REMODEL-CD): study protocol for a multicentre, open-label, pragmatic clinical trial in the USA. BMJ Open. 14(3). e077193–e077193. 4 indexed citations

Allegretti, Jessica R., Liliana Bordeianou, Oriana M. Damas, et al.. (2024). Challenges in IBD Research 2024: Pragmatic Clinical Research. Inflammatory Bowel Diseases. 30(Supplement_2). S55–S66. 2 indexed citations

Khandelwal, Pooja, Yael Haberman, Anil G. Jegga, et al.. (2023). Transcriptome analysis in acute gastrointestinal graft-<i>versus</i> host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica. 108(7). 1803–1816. 1 indexed citations

Samuels, Abigail, et al.. (2023). Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease. Current Gastroenterology Reports. 25(11). 323–332. 9 indexed citations

Smith, Julia, Chunyan Liu, Andrew F. Beck, et al.. (2023). Racial Disparities in Pediatric Inflammatory Bowel Disease Care: Differences in Outcomes and Health Service Utilization Between Black and White Children. The Journal of Pediatrics. 260. 113522–113522. 5 indexed citations

10.

Minar, Phillip, et al.. (2023). The Role of Therapeutic Drug Monitoring in Children. Gastroenterology Clinics of North America. 52(3). 549–563. 2 indexed citations

11.

Colman, Ruben J., Ron A. A. Mathôt, Johan Van Limbergen, et al.. (2023). Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn’s Disease Exhibit Similar Pharmacokinetics. Inflammatory Bowel Diseases. 30(10). 1678–1685. 2 indexed citations

12.

Colman, Ruben J., Tomoyuki Mizuno, Keizo Fukushima, et al.. (2022). Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary Pharmacology & Therapeutics. 57(5). 524–539. 12 indexed citations

13.

Colman, Ruben J., Tomoyuki Mizuno, Jeffrey S. Hyams, et al.. (2021). Antibodies‐to‐infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn’s disease. Alimentary Pharmacology & Therapeutics. 55(5). 593–603. 23 indexed citations

14.

Plevinsky, Jill M., et al.. (2020). A Micro‐longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases. Journal of Pediatric Gastroenterology and Nutrition. 71(3). 366–370. 2 indexed citations

15.

Nguyen, Huyen‐Tran, Phillip Minar, Kimberly Jackson, & Patricia C. Fulkerson. (2017). Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease. World Journal of Gastroenterology. 23(42). 7644–7652. 11 indexed citations

16.

Minar, Phillip, Kimberly Jackson, Yi‐Ting Tsai, et al.. (2017). Validation of Neutrophil CD64 Blood Biomarkers to Detect Mucosal Inflammation in Pediatric Crohn’s Disease. Inflammatory Bowel Diseases. 24(1). 198–208. 14 indexed citations

17.

Minar, Phillip, Kimberly Jackson, Yi‐Ting Tsai, et al.. (2016). A Low Neutrophil CD64 Index Is Associated with Sustained Remission During Infliximab Maintenance Therapy. Inflammatory Bowel Diseases. 22(11). 2641–2647. 8 indexed citations

18.

Waddell, Amanda, Jefferson E. Vallance, Preston D. Moore, et al.. (2015). IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function. Inflammatory Bowel Diseases. 21(12). 2737–2746. 49 indexed citations

19.

Minar, Phillip, Yael Haberman, Ingrid Jurickova, et al.. (2014). Utility of Neutrophil Fcγ Receptor I (CD64) Index as a Biomarker for Mucosal Inflammation in Pediatric Crohnʼs Disease. Inflammatory Bowel Diseases. 20(6). 1–1. 23 indexed citations

20.

Minar, Phillip, Ingrid Jurickova, Yael Haberman, et al.. (2013). Tu1940 Neutrophil FCy Receptor 1 (CD64) Index As a Non-Invasive Biomarker for Clinical and Mucosal Disease Activity in Pediatric Inflammatory Bowel Disease. Gastroenterology. 144(5). S–886. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact